GLP-1s | Medicare Policy Initiative

Skip to main content

McCourt School of Public Policy

Center on Health Insurance Reforms

Drug Pricing in the Era of Trump 2.0

The Trump Administration’s First Regulatory Action on Medicare Advantage Omits Some Prior Authorization Guardrails

Policy options to cover anti-obesity drugs: Highlighting the Georgetown policy compendium as a resource